Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

Impact of Tumor Genomic Mutations on Thrombotic Risk in Cancer Patients

Venous thromboembolism (VTE) is common in patients with cancer and is an important contributor to morbidity and mortality in these patients. Early thromboprophylaxis initiated only in those cancer patients at highest risk for VTE would be optimal. Risk stratification scores incorporating tumor locat...

Full description

Bibliographic Details
Main Authors: Orly Leiva, Jean M. Connors, Hanny Al-Samkari
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
molecular subtype
cancer
venous thromboembolism
arterial thrombosis
ALK
ROS1
Online Access:https://www.mdpi.com/2072-6694/12/7/1958

Similar Items

Similar Items